Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells
Junhe Zhang, Linlin Shan, Fan Liang, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 39
A Flexible Hybrid Site‐Specific Integration‐Based Expression System in CHO Cells for Higher‐Throughput Evaluation of Monoclonal Antibody Expression Cassettes
Alana C. Szkodny, Kelvin H. Lee
Biotechnology Journal (2025) Vol. 20, Iss. 1
Open Access
CMC Strategies and Advanced Technologies for Vaccine Development to Boost Acceleration and Pandemic Preparedness
Maria Monica Castellanos, Hervé Gressard, Xiangming Li, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1153-1153
Open Access | Times Cited: 14
Gene copy number, gene configuration and LC/HC mRNA ratio impact on antibody productivity and product quality in targeted integration CHO cell lines
Zion Lee, Jun Wan, Amy Shen, et al.
Biotechnology Progress (2024) Vol. 40, Iss. 3
Closed Access | Times Cited: 5
The new frontier in CHO cell line development: From random to targeted transgene integration technologies
Nikolas Zeh, Moritz J. Schmidt, Patrick Schulz, et al.
Biotechnology Advances (2024) Vol. 75, pp. 108402-108402
Open Access | Times Cited: 5
Towards maximum acceleration of monoclonal antibody development: Leveraging transposase-mediated cell line generation to enable GMP manufacturing within 3 months using a stable pool
Valerie Schmieder, Juergen Fieder, Raphael Drerup, et al.
Journal of Biotechnology (2022) Vol. 349, pp. 53-64
Open Access | Times Cited: 25
Reshaping cell line development and CMC strategy for fast responses to pandemic outbreak
Zheng Zhang, Chen Ji, Junghao Wang, et al.
Biotechnology Progress (2021) Vol. 37, Iss. 5
Closed Access | Times Cited: 27
Genomic barcoding for clonal diversity monitoring and control in cell-based complex antibody production
Niels Bauer, Christoph Oberist, Michaela Poth, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Streamlined Human Cell-Based Recombinase-Mediated Cassette Exchange Platform Enables Multigene Expression for the Production of Therapeutic Proteins
Seunghyeon Shin, Su Hyun Kim, Jae Seong Lee, et al.
ACS Synthetic Biology (2021) Vol. 10, Iss. 7, pp. 1715-1727
Closed Access | Times Cited: 15
A high‐fidelity, dual site‐specific integration system in CHO cells by a Bxb1 recombinase
Yifeng Xu, Kerstin B. Crowe, Paulena L. Lieske, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 2
Closed Access | Times Cited: 1
Evaluation of two transposases for improving expression of recombinant proteins in Chinese hamster ovary cell stable pools by co‐transfection and supertransfection approaches
Melina Lenser, Hanh Giai Ngo, Lily Sarrafha, et al.
Biotechnology Progress (2024)
Closed Access | Times Cited: 1
Further Accelerating Biologics Development from DNA to IND: The Journey from COVID-19 to Non-COVID-19 Programs
Kee W. Tan, Pengfei Ji, Hang Zhou, et al.
Antibody Therapeutics (2024) Vol. 7, Iss. 1, pp. 96-104
Open Access | Times Cited: 1
Novel and effective screening system for recombinant protein production in CHO cells
Junhe Zhang, Wenwen Yang, Liao Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
An arrayed CRISPR screen reveals Myc depletion to increase productivity of difficult-to-express complex antibodies in CHO cells
Niels Bauer, Benedikt Oswald, Maximilian Eiche, et al.
Synthetic Biology (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 7
Utilizing targeted integration CHO pools to potentially accelerate the GMP manufacturing of monoclonal and bispecific antibodies
Gavin C. Barnard, Michelle Zhou, Amy Shen, et al.
Biotechnology Progress (2023) Vol. 40, Iss. 1
Closed Access | Times Cited: 3
Shortening the biologics clinical timeline with a novel method for generating stable, high‐producing cell pools and clones
Chad A. Hall, Rachel H. Kravitz, Karl F. Johnson, et al.
Biotechnology and Bioengineering (2022)
Open Access | Times Cited: 6
Mitigating transcriptional bottleneck using a constitutively active transcription factor, VP16-CREB, in mammalian cells
Chansik Yoon, Kyoung Eun Baek, Dong‐Il Kim, et al.
Metabolic Engineering (2023) Vol. 80, pp. 33-44
Closed Access | Times Cited: 2
Implementation of ubiquitous chromatin opening elements as artificial integration sites for CRISPR/Cas9‐mediated knock‐in in mammalian cells
Seul Mi Kim, Jae‐Jin Lee, Jae Seong Lee
Engineering in Life Sciences (2023) Vol. 23, Iss. 4
Open Access | Times Cited: 2
Activation of the PERK branch of the unfolded protein response during production reduces specific productivity in CHO cells via downregulation of PDGFRa and IRE1a signaling
Brian M. Castellano, Danming Tang, Scot A. Marsters, et al.
Biotechnology Progress (2023) Vol. 39, Iss. 5
Closed Access | Times Cited: 2
Generation of a host cell line containing a MAR‐rich landing pad for site‐specific integration and expression of transgenes
Claudia Oliviero, Steffen C. Hinz, Jan P. Bogen, et al.
Biotechnology Progress (2022) Vol. 38, Iss. 4
Open Access | Times Cited: 4
Strategies to improve CHO cell culture performance: Targeted deletion of amino acid catabolism and apoptosis genes paired with growth inhibitor supplementation
Cynthia Lam, Alyssa Sargon, Camil Diaz, et al.
Biotechnology Progress (2024) Vol. 40, Iss. 5
Closed Access
SPEED‐MODE cell line development (CLD): Reducing Chinese hamster ovary (CHO) CLD timelines via earlier suspension adaptation and maximizing time spent in the exponential growth phase
Kavya Ganapathy, Cynthia Lam, Joni Tsukuda, et al.
Biotechnology Progress (2024) Vol. 40, Iss. 5
Closed Access
Chromatin Accessibility Plays an Important Epigenetic Role on Antibody Expression From CMV Promoter and DNA Elements Flanking the CHO TI Host Landing‐Pad
Kavya Ganapathy, Andrew McKay, Steffen Durinck, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 10
Closed Access
A ribonucleoprotein‐based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering
Joseph O. Carver, Marie Kern, Peggy Ko, et al.
Biotechnology Progress (2021) Vol. 38, Iss. 1
Closed Access | Times Cited: 4
Combining regulated and constitutive protein expression significantly boosts protein expression by increasing productivity without affecting CHO cell growth
Cynthia Lam, Joseph O. Carver, Domingos Ng, et al.
Biotechnology Progress (2023) Vol. 39, Iss. 3
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top